Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001068238-20-000055
Filing Date
2020-02-14
Accepted
2020-02-14 16:31:28
Documents
1
Group Members
DAVID COLLIERJAMES WATSONVELOCITY PHARMA MANAGEMENT, LLC

Document Format Files

Seq Description Document Type Size
1 VELOCITY PHARMACEUTICAL HOLDINGS 13G velocitypharma_13g.htm SC 13G 159195
  Complete submission text file 0001068238-20-000055.txt   161036
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Subject) CIK: 0001326190 (see all company filings)

EIN.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-80900 | Film No.: 20620778
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 OYSTER BLVD. SUITE 202 SOUTH SAN FRANCISCO CA 94080
Business Address 400 OYSTER BLVD. SUITE 202 SOUTH SAN FRANCISCO CA 94080 (650) 745-8179
VELOCITY PHARMACEUTICAL HOLDINGS LLC (Filed by) CIK: 0001802702 (see all company filings)

EIN.: 452578473 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G